These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20074562)

  • 1. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
    Takeuchi K; Tanaka A; Kato S; Amagase K; Satoh H
    Clin Chim Acta; 2010 Apr; 411(7-8):459-66. PubMed ID: 20074562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
    Takeuchi K; Tanaka A; Ohno R; Yokota A
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():165-82. PubMed ID: 15075458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
    Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
    J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
    Ohno R; Yokota A; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
    Takeuchi K; Yokota A; Tanaka A; Takahira Y
    Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats.
    Zinkievich JM; George S; Jha S; Nandi J; Levine RA
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):654-61. PubMed ID: 20082628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
    Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
    Menozzi A; Pozzoli C; Giovannini E; Solenghi E; Grandi D; Bonardi S; Bertini S; Vasina V; Coruzzi G
    Eur J Pharmacol; 2006 Dec; 552(1-3):143-50. PubMed ID: 17069793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of intestinal, but not gastric damage caused by a low dose of indomethacin in the presence of rofecoxib.
    Yokota A; Taniguchi M; Tanaka A; Takeuchi K
    Inflammopharmacology; 2005; 13(1-3):209-16. PubMed ID: 16259740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats.
    Konaka A; Nishijima M; Tanaka A; Kunikata T; Kato S; Takeuchi K
    J Physiol Pharmacol; 1999 Mar; 50(1):25-38. PubMed ID: 10210152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
    Takeuchi K; Miyazawa T; Tanaka A; Kato S; Kunikata T
    Digestion; 2002; 66(1):30-41. PubMed ID: 12379813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
    Tanaka A; Hase S; Miyazawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs.
    Tanaka A; Araki H; Komoike Y; Hase S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):21-7. PubMed ID: 11595414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both selective COX-1 and COX-2 inhibitors aggravate gastric damage induced in rats by 2-deoxy-D-glucose. relation to gastric hypermotility and COX-2 expression.
    Takeuchi K; Miyazawa T; Matsumoto M; Hayashi Y
    Digestion; 2003; 68(2-3):71-9. PubMed ID: 14581763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
    Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
    Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.